BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, Ramm GA. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. J Hepatol. 2004;41:576-583. [PMID: 15464237 DOI: 10.1016/j.jhep.2004.06.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Lewindon PJ, Shepherd RW, Walsh MJ, Greer RM, Williamson R, Pereira TN, Frawley K, Bell SC, Smith JL, Ramm GA. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011;53:193-201. [DOI: 10.1002/hep.24014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
2 Gillespie CD, O'Reilly MK, Allen GN, McDermott S, Chan VO, Ridge CA. Imaging the Abdominal Manifestations of Cystic Fibrosis. Int J Hepatol 2017;2017:5128760. [PMID: 28250993 DOI: 10.1155/2017/5128760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
3 Mueller-abt PR, Frawley KJ, Greer RM, Lewindon PJ. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. Journal of Cystic Fibrosis 2008;7:215-21. [DOI: 10.1016/j.jcf.2007.08.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
4 Valamparampil JJ, Gupte GL. Cystic fibrosis associated liver disease in children. World J Hepatol 2021; 13(11): 1727-1742 [PMID: 34904041 DOI: 10.4254/wjh.v13.i11.1727] [Reference Citation Analysis]
5 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010; 1(2): 69-84 [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
6 Pozniak KN, Pearen MA, Pereira TN, Kramer CSM, Kalita-De Croft P, Nawaratna SK, Fernandez-Rojo MA, Gobert GN, Tirnitz-Parker JEE, Olynyk JK, Shepherd RW, Lewindon PJ, Ramm GA. Taurocholate Induces Biliary Differentiation of Liver Progenitor Cells Causing Hepatic Stellate Cell Chemotaxis in the Ductular Reaction: Role in Pediatric Cystic Fibrosis Liver Disease. Am J Pathol. 2017;187:2744-2757. [PMID: 28935574 DOI: 10.1016/j.ajpath.2017.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Leung DH. Hepatic fibrosis scores and serum biomarkers in pediatric hepatology. Clin Liver Dis (Hoboken) 2017;9:125-30. [PMID: 30992975 DOI: 10.1002/cld.634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Sahab ZJ, Semaan SM, Sang QA. Methodology and Applications of Disease Biomarker Identification in Human Serum. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200034] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 11.4] [Reference Citation Analysis]
9 Lebensztejn DM, Skiba E, Tobolczyk J, Sobaniec-Lotowska ME, Kaczmarski M. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol 2005;11:7192-6. [PMID: 16437671 DOI: 10.3748/wjg.v11.i45.7192] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
10 Lu WJ, Saxena N, Luk JM, Kaul SC, Wadhwa R. Circulating mortalin autoantibody--a new serological marker of liver cirrhosis. Cell Stress Chaperones 2015;20:715-9. [PMID: 25905813 DOI: 10.1007/s12192-015-0592-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Stonebraker JR, Ooi CY, Pace RG, Corvol H, Knowles MR, Durie PR, Ling SC. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis. Clin Gastroenterol Hepatol 2016;14:1207-1215.e3. [PMID: 27062904 DOI: 10.1016/j.cgh.2016.03.041] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 9.3] [Reference Citation Analysis]
12 Peng Y, Shi M, Kong J. Detection of Biomarkers for Liver Fibrosis Using High-Throughput Electrochemical Microimmunosensor. Electroanalysis 2008;20:1953-8. [DOI: 10.1002/elan.200804250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
13 Meng L, Huang M, Ye X, Fan M, Bian Z. Increased expression of collagen prolyl 4-hydroxylases in Chinese patients with hereditary gingival fibromatosis. Arch Oral Biol 2007;52:1209-14. [PMID: 17825243 DOI: 10.1016/j.archoralbio.2007.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
14 Chen W, Zhou Z, Ren Y, Zhang L, Sun L, Man Y, Wang Z. Effects of long non-coding RNA LINC00667 on renal tubular epithelial cell proliferation, apoptosis and renal fibrosis via the miR-19b-3p/LINC00667/CTGF signaling pathway in chronic renal failure. Cellular Signalling 2019;54:102-14. [DOI: 10.1016/j.cellsig.2018.10.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
15 Staufer K, Halilbasic E, Trauner M, Kazemi-Shirazi L. Cystic fibrosis related liver disease--another black box in hepatology. Int J Mol Sci 2014;15:13529-49. [PMID: 25093717 DOI: 10.3390/ijms150813529] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
16 Mercedes R, Brown J, Minard C, Tsai CM, Devaraj S, Munden M, Leung D. A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis. Glob Pediatr Health 2020;7:2333794X20938931. [PMID: 32821773 DOI: 10.1177/2333794X20938931] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Pereira TN, Lewindon PJ, Greer RM, Hoskins AC, Williamson RM, Shepherd RW, Ramm GA. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:328-35. [PMID: 22157922 DOI: 10.1097/MPG.0b013e3182432034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
18 Malvoisin E, Makhloufi D, Livrozet JM. Searching for biomarkers of comorbidities in sera of treated HIV-infected patients by isoelectric focusing. Electrophoresis 2015;36:1251-5. [PMID: 25630581 DOI: 10.1002/elps.201400535] [Reference Citation Analysis]
19 Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10 Suppl 2:S29-S36. [PMID: 21658639 DOI: 10.1016/s1569-1993(11)60006-4] [Cited by in Crossref: 233] [Cited by in F6Publishing: 69] [Article Influence: 21.2] [Reference Citation Analysis]
20 Zhu Q, Trau D. Multiplex detection platform for tumor markers and glucose in serum based on a microfluidic microparticle array. Anal Chim Acta 2012;751:146-54. [PMID: 23084064 DOI: 10.1016/j.aca.2012.09.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
21 Keller LM, Eighmy S, Li C, Winter L, Kerecman J, Goodman Z, Mittal N, Blanco CL. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp. PLoS One 2020;15:e0228985. [PMID: 32150543 DOI: 10.1371/journal.pone.0228985] [Reference Citation Analysis]
22 Calvopina DA, Chatfield MD, Weis A, Coleman MA, Fernandez-rojo MA, Noble C, Ramm LE, Leung DH, Lewindon PJ, Ramm GA. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis: Hepatology. Hepatology 2018;68:2301-16. [DOI: 10.1002/hep.30156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
23 Marinho CC, Bretas T, Voieta I, Queiroz LCD, Ruiz-guevara R, Teixeira AL, Antunes CM, Prata A, Lambertucci JR. Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil. Mem Inst Oswaldo Cruz 2010;105:471-8. [DOI: 10.1590/s0074-02762010000400020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Debray D, Corvol H, Housset C. Modifier genes in cystic fibrosis-related liver disease. Curr Opin Gastroenterol 2019;35:88-92. [PMID: 30585791 DOI: 10.1097/MOG.0000000000000508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
25 Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, Miller G, Lewindon PJ, Shepherd RW, Ramm GA. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease: Leung et al. Hepatology 2015;62:1576-83. [DOI: 10.1002/hep.28016] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
26 Kanamoto M, Shimada M, Ikegami T, Uchiyama H, Imura S, Morine Y, Kanemura H, Arakawa Y, Nii A. Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg. 2009;16:463-467. [PMID: 19322509 DOI: 10.1007/s00534-009-0075-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
27 Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, Wakui Y, Kido O, Ninomiya M, Kogure T. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008;43:720-728. [PMID: 18807134 DOI: 10.1007/s00535-008-2225-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
28 Orasan OH, Ciulei G, Cozma A, Sava M, Dumitrascu DL. Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies. Clujul Med 2016;89:24-31. [PMID: 27004022 DOI: 10.15386/cjmed-554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
29 Flass T, Narkewicz MR. Cirrhosis and other liver disease in cystic fibrosis. J Cyst Fibros. 2013;12:116-124. [PMID: 23266093 DOI: 10.1016/j.jcf.2012.11.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
30 Leung DH, Narkewicz MR. Cystic Fibrosis-related cirrhosis. Journal of Cystic Fibrosis 2017;16:S50-61. [DOI: 10.1016/j.jcf.2017.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
31 Harada N, Soejima Y, Taketomi A, Yoshizumi T, Ikegami T, Yamashita Y, Itoh S, Kuroda Y, Maehara Y. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation. 2008;85:69-74. [PMID: 18192914 DOI: 10.1097/01.tp.0000297248.18483.16] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
32 Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA. Circulating MicroRNAs as Noninvasive Diagnostic Biomarkers of Liver Disease in Children With Cystic Fibrosis. Journal of Pediatric Gastroenterology & Nutrition 2015;60:247-54. [DOI: 10.1097/mpg.0000000000000600] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
33 Gawron K, Łazarz-Bartyzel K, Potempa J, Chomyszyn-Gajewska M. Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet J Rare Dis 2016;11:9. [PMID: 26818898 DOI: 10.1186/s13023-016-0395-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
34 Nagelkerke SCJ, Draijer LG, Benninga MA, Koot BGP, Tabbers MM. The prevalence of liver fibrosis according to non-invasive tools in a pediatric home parenteral nutrition cohort. Clin Nutr 2021;40:460-6. [PMID: 32636112 DOI: 10.1016/j.clnu.2020.05.039] [Reference Citation Analysis]
35 Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, Leonardi S. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13:e11215. [PMID: 24171010 DOI: 10.5812/hepatmon.11215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
36 Eulenberg VM, Lidbury JA. Hepatic Fibrosis in Dogs. J Vet Intern Med. 2018;32:26-41. [PMID: 29194760 DOI: 10.1111/jvim.14891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]